TrialJournal for immunotherapy of cancer2025

Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

Robert L Ferris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.